Simtriyo

Just before the start of the school year, as more parents are re-examining treatment options for Attention Deficit Hyperactivity Disorder (ADHD), a new drug has been approved in the United States that is generating significant interest in the medical community. It is Simtriyo (centanafadine), which was recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of children...